BERGANTINI LAURA | Elenco docenti

Gangi, S., Bergantini, L., Paggi, I., Spalletti, M., Cameli, P., Bargagli, E., et al. (2025). Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis. IMMUNITY, INFLAMMATION AND DISEASE, 13(1) [10.1002/iid3.70123]. - dettaglio
Fontana, A., Bergantini, L., Carullo, G., Scalvini, L., D'Alessandro, M., Papulino, C., et al. (2024). Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE [10.1021/acsptsci.4c00456]. - dettaglio
Bergantini, L., Gangi, S., D'Alessandro, M., Cameli, P., Perea, B., Meocci, M., et al. (2024). Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19. IMMUNOBIOLOGY, 229(4) [10.1016/j.imbio.2024.152813]. - dettaglio
D'Alessandro, M., Cameli, P., Cotton, C.V., Lamb, J.A., Bergantini, L., Gangi, S., et al. (2024). Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease. PLOS ONE, 19(10) [10.1371/journal.pone.0311357]. - dettaglio
Conticini, E., Cameli, P., Grazzini, S., D'Alessandro, M., Bergantini, L., Porcelli, B., et al. (2024). Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study. SEMINARS IN ARTHRITIS AND RHEUMATISM, 69 [10.1016/j.semarthrit.2024.152560]. - dettaglio

Tutte le pubblicazioni